Sangamo Therapeutics (SGMOQ) Gains from Investment Securities (2014 - 2015)
Sangamo Therapeutics' (SGMOQ) quarterly Gains from Investment Securities came in at -$1.8 million in Q1 2015, down 3700.0% year-on-year from $50000.0 in Q1 2014, and down 1900.0% quarter-over-quarter from $100000.0 in Q4 2014.
Sangamo Therapeutics (SGMOQ) Gains from Investment Securities (2014 - 2015) Analysis & Trends
Sangamo Therapeutics' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$1.8 million for Q1 2015.
- On a quarterly basis, Gains from Investment Securities fell 3700.0% year-over-year to -$1.8 million in Q1 2015; TTM through Dec 2015 was -$1.8 million, a 882.61% decrease from a year earlier, with the FY2015 full-year figure at -$1.8 million, down 882.61% from the prior year.
- Gains from Investment Securities slipped to -$1.8 million in Q1 2015 per SGMOQ's latest filing, from $100000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $100000.0 in Q4 2014 and bottomed at -$1.8 million in Q1 2015.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | -1.80 Mn |
| Mar 31, 2015 | -1.80 Mn |
| Dec 31, 2014 | 100,000.00 |
| Dec 31, 2014 | 100,000.00 |
| Sep 30, 2014 | 50,000.00 |
| Sep 30, 2014 | 50,000.00 |
| Jun 30, 2014 | 30,000.00 |
| Jun 30, 2014 | 30,000.00 |
| Mar 31, 2014 | 50,000.00 |
| Mar 31, 2014 | 50,000.00 |